Glaukos Corporation
GKOSNYSEHealthcare● Active
$121.96
$-3.04(-2.43%)
Market Cap$7.2B
P/E Ratio—
52W High$148.11
52W Low$73.16
Glaukos Corporation（GKOS）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GKOS · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.13B) | ($0.15B) | ($0.13B) | ($0.10B) | ($0.05B) |
| Depreciation & Amort. | $0.04B | $0.04B | $0.04B | $0.04B | $0.03B |
| Stock-Based Comp. | $0.06B | $0.05B | $0.04B | $0.04B | $0.03B |
| Change in Working Capital | ($0.03B) | ($0.04B) | ($0.01B) | ($0.01B) | $0.00B |
| Net Cash from Operations | ($0.05B) | ($0.06B) | ($0.06B) | ($0.03B) | $0.02B |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.01B) | ($0.02B) | ($0.03B) | ($0.05B) |
| Purchases of Investments | ($0.23B) | ($0.19B) | ($0.27B) | ($0.06B) | ($0.22B) |
| Sales of Investments | $0.20B | $0.25B | $0.30B | $0.14B | $0.21B |
| Net Cash from Investing | ($0.08B) | $0.05B | $0.01B | $0.04B | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.05B | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Cash from Financing | $0.01B | $0.09B | $0.02B | $0.01B | $0.04B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.05B) | ($0.07B) | ($0.08B) | ($0.06B) | ($0.02B) |
| FCF Margin %(computed) | -10.64% | -17.63% | -24.79% | -22.40% | -7.85% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Glaukos Corporation
关于Glaukos Corporation（GKOS）现金流量表
Glaukos Corporation 2025财年经营活动现金流($0.05B)，自由现金流($0.05B)（FCF利润率-10.64%），资本支出($0.01B)。
常见问题
GKOS · 4 问Glaukos Corporation 2025财年自由现金流($0.05B)，同比up20.1%。
GKOS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10